October 30, 2021Journal of the American Heart AssociationOpen Access

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes

View Full Paper

Ask AI

Bookmark

Why the study?

Information on outcomes other than mortality associated with dysglycemia at acute myocardial infarction is less well explored in patients without diabetes from a long-term perspective.

Does elevated admission glucose increase the risk of long-term complications in patients with AMI without diabetes?

Population

45 468 patients without diabetes with AMI and admission glucose <=11 mmol/L (<=198 mg/dL)

Comparison

Categorized admission glucose levels vs reference glucose 4.0-6.0 mmol/L (72-109 mg/dL)

Design

Nationwide registry-based cohort study

Follow-up

Mean 3.3+/-1.7 years

Discussion

Member takes

Overview

Admission hyperglycemia may stratify long-term risk after AMI without diabetes; leaves open whether glucose-targeted interventions improve outcomes.

Structured PICO

Does elevated admission glucose increase the risk of long-term complications in patients with AMI without diabetes?

Population

45,468 patients without diabetes with acute myocardial infarction (AMI) and admission glucose ≤11 mmol/L (≤198 mg/dL) registered in the SWEDEHEART registry.

Intervention

Elevated admission glucose levels (7.8-11.0 mmol/L [140-198 mg/dL])

Comparator

Normal admission glucose levels (4.0-6.0 mmol/L [72-109 mg/dL])

Outcome

Long-term outcomes including acute myocardial infarction, heart failure, stroke, renal failure, and deathhard clinical

Elevated admission glucose levels in non-diabetic patients with AMI are associated with an increased long-term risk of heart failure, renal failure, and death, highlighting its utility in risk stratification.

Cite This Study

A 2021 study studied this question.

synapsesocial.com/papers/6a87b1e53f31f6b699bb5109 https://doi.org/10.1161/jaha.121.022667

View Full Paper

Ask AI

Bookmark

October 30, 2021Journal of the American Heart AssociationOpen Access

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes

View Full Paper

Ask AI

Bookmark

Why the study?

Information on outcomes other than mortality associated with dysglycemia at acute myocardial infarction is less well explored in patients without diabetes from a long-term perspective.

Does elevated admission glucose increase the risk of long-term complications in patients with AMI without diabetes?

Population

45 468 patients without diabetes with AMI and admission glucose <=11 mmol/L (<=198 mg/dL)

Comparison

Categorized admission glucose levels vs reference glucose 4.0-6.0 mmol/L (72-109 mg/dL)

Design

Nationwide registry-based cohort study

Follow-up

Mean 3.3+/-1.7 years

Discussion

Member takes

Overview

Admission hyperglycemia may stratify long-term risk after AMI without diabetes; leaves open whether glucose-targeted interventions improve outcomes.

Structured PICO

Does elevated admission glucose increase the risk of long-term complications in patients with AMI without diabetes?

Population

45,468 patients without diabetes with acute myocardial infarction (AMI) and admission glucose ≤11 mmol/L (≤198 mg/dL) registered in the SWEDEHEART registry.

Intervention

Elevated admission glucose levels (7.8-11.0 mmol/L [140-198 mg/dL])

Comparator

Normal admission glucose levels (4.0-6.0 mmol/L [72-109 mg/dL])

Outcome

Long-term outcomes including acute myocardial infarction, heart failure, stroke, renal failure, and deathhard clinical

Cite This Study

A 2021 study studied this question.

synapsesocial.com/papers/6a87b1e53f31f6b699bb5109 https://doi.org/10.1161/jaha.121.022667

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark